Table 2: Recipient characteristics.

Sevoflurane groupControl groupMann-Whitney, value

Recipient age, y44 (28–55)49 (34–55)0,865*
MELD score20 (15–27)17 (14–26)0,340*
Baseline AST, IU/L86 (32–154)90 (34–171)0,955*
Baseline ALT, IU/L62 (17–126)63 (20–220)0,985*
Beta-blocker therapy, y/n17/1315/150,796**

Data are as median (interquartile range).
*Mann-Whitney test, **Fisher’s exact test, two tailed.